The drug industry’s top lobbying group is appealing its latest loss in its challenge to Medicare’s Drug Price Negotiation Program to the Fifth Circuit, returning the case to an appeals court that has ...

A federal appeals panel voted 2-to-1 against a group of international aid groups, ruling they did not have the legal standing to bring a lawsuit. Meanwhile, the Trump administration has ordered a ...

Drug companies have formed a new group to present lawmakers with research on what the industry sees as the negative impacts ...

Our Drug Pricing and Market Access team tracks recent developments in healthcare reform, the Medicaid Drug Rebate Program, the 340B Program, ...

Hospital and health system groups are skeptical the Trump administration will have enough time to weigh and incorporate ...

The Inflation Reduction Act (IRA) authorized the federal government to force prescription drug manufacturers to "negotiate" drug prices for ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Pharma industry loses on Medicare price ...

A normally hard-headed bench just endorsed President Biden’s scheme to dictate how much drugmakers can charge under Medicare.

Learn about the benefits that become permanent features of Medicare in 2026 and how they have been changed or updated since their inception.

Democratic Sens. Ron Wyden and Elizabeth Warren have asked to see internal company documents after a Guardian investigation alleged that the company partnered with nursing homes across the country to ...

The Trump administration has been talking to drugmakers about ways to raise prices of medicines in Europe and elsewhere to ...

Drug companies and organizations challenging the Medicare drug negotiations have yet to convince a U.S. court that the process, mandated by the 2022 Inflation Reduction Act, violates the Constitution.